IBIO iBio Inc

Price (delayed)

$1.245

Market cap

$80.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.32

Enterprise value

$25.64M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 26
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 24

iBio is a cutting-edge biotech company leveraging AI and advanced computational biology to develop next-generation biopharmaceuticals for cardiometabolic diseases, obesity, cancer and other hard-to-treat diseases. By combining proprietary 3D modeling ...

Highlights
The EPS has soared by 82% YoY and by 44% from the previous quarter
IBIO's debt is down by 38% YoY and by 5% from the previous quarter
The company's net income has shrunk by 80% YoY and by 20% QoQ
iBio's revenue has shrunk by 75% YoY and by 67% QoQ

Key stats

What are the main financial stats of IBIO

IBIO stock price

How has the iBio stock price performed over time
Intraday
-6.39%
1 week
5.51%
1 month
-12.94%
1 year
56.15%
YTD
-35.49%
QTD
-28.86%

Financial performance

How have iBio's revenue and profit performed over time
Revenue
$100,000
Gross profit
$100,000
Operating income
-$35.14M
Net income
-$33.04M
Gross margin
100%
Net margin
-33,044%
The operating income has dropped by 89% year-on-year and by 21% since the previous quarter
The company's net income has shrunk by 80% YoY and by 20% QoQ
iBio's revenue has shrunk by 75% YoY and by 67% QoQ
iBio's gross profit has shrunk by 75% YoY and by 67% QoQ

Price vs fundamentals

How does IBIO's price correlate with its fundamentals

Growth

What is iBio's growth rate over time

Valuation

What is iBio stock price valuation
P/E
N/A
P/B
0.72
P/S
1,295.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
256.38
The EPS has soared by 82% YoY and by 44% from the previous quarter
IBIO's price to book (P/B) is 30% lower than its 5-year quarterly average of 1.1 but 10% higher than its last 4 quarters average of 0.7
The company's equity rose by 11% QoQ
iBio's revenue has shrunk by 75% YoY and by 67% QoQ
IBIO's price to sales (P/S) is 68% more than its last 4 quarters average of 826.0

Efficiency

How efficient is iBio business performance
iBio's return on equity has surged by 62% YoY and by 11% QoQ
The ROIC has soared by 55% YoY and by 7% from the previous quarter
iBio's return on assets has increased by 49% YoY and by 9% QoQ

Dividends

What is IBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IBIO.

Financial health

How did iBio financials performed over time
The company's total liabilities has surged by 61% QoQ and by 61% YoY
IBIO's current ratio is down by 34% since the previous quarter
IBIO's debt is 97% less than its equity
The company's debt to equity has shrunk by 88% YoY
IBIO's debt is down by 38% YoY and by 5% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.